To do so, we first generated Caco-2BBe1 cell lines carrying the IBD patient associated SNP rs1893217 (PTPN2-KI) cells and a complete knock-out of the PTPN2 gene (PTPN2-KO) by CRISPR-Cas9 gene editing. The gene discussed is PTPN2; the disease is inflammatory bowel disease.